Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Teitelbaum Law Group
- Blitman & King
- Porzio Bromberg
- Godfrey & Kahn
- Himes Petrarca
- BatesCarey
- Lowe Stein
- Terrell Hogan
- Skadden Arps
- Brown Rudnick
- Ballard Spahr
- WilmerHale
- Davis Polk
- Spangenberg Shibley
- Potter Anderson
- Porter Hedges
- Gage Spencer & Fleming
- Consovoy McCarthy
- Gertz & Rosen
- Andrews & Thornton
- Joseph Hage
- ASK LLP
- Cuneo Gilbert
- Pashman Stein
- WestLoop Law
- Phillips Lytle
- Slevin & Hart
- Gilbert LLP
- McGrail & Bensinger
- Bentley & Bruning
- Pachulski Stang
- Lerner Arnold
- Kramer Levin
- Bialson Bergen
- Bielli & Klauder
- ArentFox Schiff LLP
- Martin S. Rapaport
- Marino Tortorella
- Cronin Fried
- Lite DePalma
- Saul Ewing
- Taft Stettinius
- Wilk Auslander
- Stutzman Bromberg
- Dechert LLP
- King & Spalding
- Kirkland & Ellis
- ArentFox Schiff
- Brown & Connery
- Hagens Berman
- Keller Rohrback
- Napoli Shkolnik
- Robins Kaplan
- Marcus & Shapira
- Simmons Hanly
- Motley Rice
- Faegre Drinker
- Blank Rome
- Debevoise & Plimpton
- Mintz Levin
- Simpson Thacher & Bartlett LLP
- Shafferman & Feldman
- Arnold & Porter
- Goodwin Procter
- Hughes Socol
- Crowell & Moring
- Reed Smith
- Burke Warren
- Stevens & Lee
- Cleary Gottlieb
- Dentons
- O'Melveny & Myers
- Kleinberg Kaplan
- Katsky Korins
- Clifford Law Offices
- Barack Ferrazzano
- Sherrard Roe
- Levenfeld Pearlstein
- Squire Patton
- Rothstein Mandell
- Doster Ullom
- MacElree Harvey
- Hurwitz Fine
- UB Greensfelder
- Miller Nash LLP
- Keller Postman
- Pullman & Comley
- Loeb & Loeb
- Mehri & Skalet
- MoloLamken
- Shook Hardy
- Morgan Lewis
- Tarter Krinsky
- Tate Law Group LLC
- Klehr Harrison
- Jones Day
- Frost Brown
- Lowey Dannenberg
- Williams Mullen
- Porteous Hainkel
- Kobre & Kim
- Wachtell Lipton
- Waldrep Wall
- Quinn Emanuel
- Ifrah Law
- Seward & Kissel
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- Duane Morris
- Troutman
- Pillsbury Winthrop
- O'Brien Belland
- Foley & Lardner
- Seyfarth Shaw
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Schulte Roth
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Nardello & Co. LLC
- CVS Health Corp.
- Impax Laboratories, Inc.
- Sandoz International GmbH
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Omnicare Inc.
- Endo International PLC
- Province LLC
- United Parcel Service Inc.
- Avrio Health LP
- Express Scripts Holding Co.
- Hain Capital Group LLC
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- Loblaw Cos.
- TR Capital Management LLC
- AXA XL Ltd.
- The Cigna Group
- Ironshore Inc.
- Noramco Inc.
- Blue Cross Blue Shield Association
- Alaska Native Tribal Health Consortium
- Walmart Inc.
- Viatris Inc.
- Anda Inc.
- AlixPartners LLP
- Allergan PLC
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- FTI Consulting Inc.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Tucson Medical Center
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Old Republic Insurance Co.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Otis Worldwide Corp.
- DuPont de Nemours Inc.
- Cencora Inc.
- Oracle Corp.
- Giant Eagle Inc.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- McKesson Corp.
- Houlihan Lokey Inc.
- Johnson & Johnson
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Seldovia Village Tribe
- Commonwealth of Massachusetts
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Pala Band of Mission Indians
- Town of Ramapo, New York
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Nez Perce Tribe
- Port Gamble S'Klallam Tribe
- State of Nevada
- Borough of Paramus, New Jersey
- State of Indiana
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- St. Regis Mohawk Tribe
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Hopi Tribe
- Tennessee Attorney General's Office
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
July 12, 2021
US Trustee Calls For Hold On $29M In Purdue Bonuses
The U.S. Trustee's Office on Monday asked a New York bankruptcy judge to reject Purdue Pharma's request to pay up to $29 million in employee bonuses, saying that with the company possibly on the verge of reorganization the issue should be put on hold.
-
June 30, 2021
Reps Urge DOJ To Deny Sacklers Releases In Purdue Ch. 11
Two members of the House Committee on Oversight and Reform urged Attorney General Merrick Garland to oppose confirmation of the Chapter 11 plan of drugmaker Purdue Pharma, saying granting releases to the company's ownership would be incompatible with the U.S. Department of Justice's position on non-debtor releases.
-
June 29, 2021
Bankrupt Purdue Pitches $5.39M Exec Payment Plan
Purdue Pharma asked a New York bankruptcy court Monday to approve the OxyContin drugmaker's 2021 employee incentive and retention plans, which propose to pay its top five executives up to $5.39 million this year, with its general counsel receiving a seven-figure pay package.
-
June 16, 2021
Examiner With Narrow Scope Approved In Purdue Ch. 11
A New York bankruptcy judge begrudgingly approved the appointment of an examiner in the Chapter 11 case of OxyContin maker Purdue Pharma LP on Wednesday, saying he was doing so only because the baseless allegations included in the examiner motion needed to be addressed publicly.
-
June 14, 2021
Purdue Hits Back At Creditor's Motion For Ch. 11 Examiner
Bankrupt OxyContin maker Purdue Pharma LP attacked a creditor's motion seeking the appointment of a Chapter 11 examiner, telling a New York judge that the creditor's arguments that the debtor's owners steamrolled the company into accepting a $4.5 billion settlement are baseless and would threaten the debtor's proposed Chapter 11.
-
June 03, 2021
Purdue Asks To Extend Opioid Suit Shield To End Of Summer
Purdue Pharma has asked a New York bankruptcy judge for a 75-day extension on an injunction pausing suits over opioid sales against it and its owners, the Sackler family, saying they need protection as they "sprint" to the confirmation of Purdue's Chapter 11 plan.
-
May 26, 2021
Purdue Statement Gives Creditors Enough Info, Judge Says
A New York bankruptcy judge gave a preliminary nod Wednesday to Purdue Pharma's Chapter 11 plan disclosures, but held off on an approval order after the drugmaker said it needed to clear up some disputes and add a few details to the statement.
-
May 24, 2021
Purdue's New Ch. 11 Plan Docs Detail Claims Trust Framework
Bankrupt drug manufacturer Purdue Pharma LP filed an amended Chapter 11 plan and supporting documents Monday in New York court that provide details on how $1.4 billion in distributions will be shared by different groups of claimants in the case.
-
May 20, 2021
Purdue Says It May Have To Push Back Ch. 11 Schedule
Drugmaker Purdue Pharma told a New York bankruptcy judge Thursday that it may not be able to keep to the schedule it set for its Chapter 11 case, saying it is hitting some "intractable" issues as it negotiates the terms of its restructuring.
-
May 12, 2021
Purdue's Ch. 11 Confirmation Hearing Set For August
A New York bankruptcy judge on Wednesday approved a motion setting an August date for Purdue Pharma's Chapter 11 plan confirmation hearing, assuming the drugmaker's plan disclosure statement is approved next week.